127 related articles for article (PubMed ID: 8165194)
1. Efflux of zidovudine and 2',3'-dideoxyinosine out of the cerebrospinal fluid when administered alone and in combination to Macaca nemestrina.
Tuntland T; Ravasco RJ; al-Habet S; Unadkat JD
Pharm Res; 1994 Feb; 11(2):312-7. PubMed ID: 8165194
[TBL] [Abstract][Full Text] [Related]
2. Effect of age on distribution of zidovudine (azidothymidine) into the cerebrospinal fluid of Macaca nemestrina.
Lopez-Anaya A; Unadkat JD; Calkins DF; Smith AL
Pharm Res; 1993 Sep; 10(9):1338-40. PubMed ID: 8234173
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of zidovudine and dideoxyinosine alone and in combination in children with HIV infection.
Gibb D; Barry M; Ormesher S; Nokes L; Seefried M; Giaquinto C; Back D
Br J Clin Pharmacol; 1995 May; 39(5):527-30. PubMed ID: 7669489
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of zidovudine and dideoxyinosine alone and in combination in patients with the acquired immunodeficiency syndrome.
Barry M; Howe JL; Ormesher S; Back DJ; Breckenridge AM; Bergin C; Mulcahy F; Beeching N; Nye F
Br J Clin Pharmacol; 1994 May; 37(5):421-6. PubMed ID: 8054247
[TBL] [Abstract][Full Text] [Related]
5. Effect of zidovudine on transplacental pharmacokinetics of ddI in the pigtailed macaque (Macaca nemestrina).
Pereira CM; Nosbisch C; Baughman WL; Unadkat JD
Antimicrob Agents Chemother; 1995 Feb; 39(2):343-5. PubMed ID: 7726494
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of zidovudine (azidothymidine). I. Transplacental transfer.
Lopez-Anaya A; Unadkat JD; Schumann LA; Smith AL
J Acquir Immune Defic Syndr (1988); 1990; 3(10):959-64. PubMed ID: 2398459
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of didanosine and drug resistance mutations in infants exposed to zidovudine during gestation or postnatally and treated with didanosine or zidovudine in the first three months of life.
Kovacs A; Cowles MK; Britto P; Capparelli E; Fowler MG; Moye J; McIntosh K; Rathore MH; Pitt J; Husson RN
Pediatr Infect Dis J; 2005 Jun; 24(6):503-9. PubMed ID: 15933559
[TBL] [Abstract][Full Text] [Related]
8. Transplacental pharmacokinetics of dideoxyinosine in pigtailed macaques.
Pereira CM; Nosbisch C; Winter HR; Baughman WL; Unadkat JD
Antimicrob Agents Chemother; 1994 Apr; 38(4):781-6. PubMed ID: 8031046
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of dideoxyinosine in pigtailed macaques (Macaca nemestrina) after intravenous and subcutaneous administration.
Ravasco RJ; Unadkat JD; Tsai CC; Nosbisch C
J Acquir Immune Defic Syndr (1988); 1992 Oct; 5(10):1016-8. PubMed ID: 1453316
[TBL] [Abstract][Full Text] [Related]
10. In vivo maternal-fetal-amniotic fluid pharmacokinetics of zidovudine in the pigtailed macaque: comparison of steady-state and single-dose regimens.
Tuntland T; Odinecs A; Nosbisch C; Unadkat JD
J Pharmacol Exp Ther; 1998 Apr; 285(1):54-62. PubMed ID: 9535994
[TBL] [Abstract][Full Text] [Related]
11. Dose dependence in the plasma pharmacokinetics and uptake kinetics of 2',3'-dideoxyinosine into brain and cerebrospinal fluid of rats.
Hoesterey BL; Galinsky RE; Anderson BD
Drug Metab Dispos; 1991; 19(5):907-12. PubMed ID: 1686234
[TBL] [Abstract][Full Text] [Related]
12. Penetration of zidovudine into the cerebrospinal fluid of patients infected with HIV.
Burger DM; Kraaijeveld CL; Meenhorst PL; Mulder JW; Koks CH; Bult A; Beijnen JH
AIDS; 1993 Dec; 7(12):1581-7. PubMed ID: 8286068
[TBL] [Abstract][Full Text] [Related]
13. Intracellular activation and cytotoxicity of three different combinations of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine.
Palmer S; Cox S
AIDS Res Hum Retroviruses; 1995 Oct; 11(10):1227-33. PubMed ID: 8573379
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic evaluation of drug interactions with anti-HIV drugs, II: Effect of 2',3'-dideoxyinosine (ddI) on zidovudine kinetics in monkeys.
Gallo JM; Finco TS; Swagler AR; Mehta MU; Viswanathan CT; Qian M
AIDS Res Hum Retroviruses; 1992 Feb; 8(2):277-83. PubMed ID: 1540413
[TBL] [Abstract][Full Text] [Related]
15. Distributed model analysis of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine distribution in brain tissue and cerebrospinal fluid.
Takasawa K; Terasaki T; Suzuki H; Ooie T; Sugiyama Y
J Pharmacol Exp Ther; 1997 Sep; 282(3):1509-17. PubMed ID: 9316866
[TBL] [Abstract][Full Text] [Related]
16. Absorption and elimination kinetics of zidovudine in the cerebrospinal fluid in HIV-1-infected patients.
Rolinski B; Bogner JR; Sadri I; Wintergerst U; Goebel FD
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jul; 15(3):192-7. PubMed ID: 9257653
[TBL] [Abstract][Full Text] [Related]
17. Didanosine.
Shelton MJ; O'Donnell AM; Morse GD
Ann Pharmacother; 1992 May; 26(5):660-70. PubMed ID: 1350471
[TBL] [Abstract][Full Text] [Related]
18. A randomized study of combined zidovudine-lamivudine versus didanosine monotherapy in children with symptomatic therapy-naive HIV-1 infection. The Pediatric AIDS Clinical Trials Group Protocol 300 Study Team.
McKinney RE; Johnson GM; Stanley K; Yong FH; Keller A; O'Donnell KJ; Brouwers P; Mitchell WG; Yogev R; Wara DW; Wiznia A; Mofenson L; McNamara J; Spector SA
J Pediatr; 1998 Oct; 133(4):500-8. PubMed ID: 9787687
[TBL] [Abstract][Full Text] [Related]
19. Zidovudine therapy and HIV type 1 mutations in children with symptomatic HIV type 1 infection: effect of switching to didanosine or zidovudine plus didanosine therapy. Italian Multicenter Study Group on HIV Mutations in Children.
Principi N; Marchisio P; Esposito S; Rossi P; Gattinara GC; Galli L; Gabiano C; Zuccotti GV; Orlandi P
AIDS Res Hum Retroviruses; 1998 Dec; 14(18):1653-9. PubMed ID: 9870319
[TBL] [Abstract][Full Text] [Related]
20. Penetration of 3'-amino-3'-deoxythymidine, a cytotoxic metabolite of zidovudine, into the cerebrospinal fluid of HIV-1-infected patients.
Hoetelmans RM; Kraaijeveld CL; Meenhorst PL; Mulder JW; Burger DM; Koks CH; Beijnen JH
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jun; 15(2):131-6. PubMed ID: 9241112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
